Long-term docosahexaenoic acid (DHA) supplementation in cystic fibrosis patients: a randomized, multi-center, double-blind, placebo-controlled trial
Alejandro López-Neyra*, Lucrecia Suárez, Marta Muñoz, Ana de Blas, Marta Ruiz de Valbuena, María Garriga, Joaquim Calvo, Carmen Ribes, Rosa Girón Moreno, Luis Máiz, David González, Carlos Bousoño, Javier Manzanares, Óscar Pastor, Javier Martínez-Botas, Rosa del Campo, Rafael Cantón, Garbiñe Roy, Miriam Menacho, David ArroyoJavier Zamora, Joan B. Soriano, Adelaida Lamas
Research output: Contribution to journal › Article › peer-review
1Citation
(Scopus)
Fingerprint
Dive into the research topics of 'Long-term docosahexaenoic acid (DHA) supplementation in cystic fibrosis patients: a randomized, multi-center, double-blind, placebo-controlled trial'. Together they form a unique fingerprint.